The Food and Drug Administration has raised concerns about the manufacturing practices at a factory owned by Ranbaxy Laboratories, the Indian drugmaker said on Monday, sending its shares down to nearly a one-month low.
FDA raises more concerns about Ranbaxy's India plants
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.